Join to access to all OVN content. Join for Free

Results for 'industry'

Job Search Checklist for Aspiring Medical Science Liaisons
Partner Avatar Tom Caravela
Job Search Checklist for Aspiring Medical Science Liaisons

Medical Science Liaison, MSL role, MSL career tips, Pharmaceutical industry jobs, Break into MSL career

Tips to Help Break into Your First MSL Role  The Medical Science Liaison (MSL) role, has become one of the most sought-after career paths in the Pharmaceutical and Biotech industry. What does it take to land a role as a Medical Science Liaison? As an MSL Recruiter, this is a question that I am…

May 17th • 2 mins read

Positioning Yourself to Become an MSL in 2022
Partner Avatar Bridget Rasmusson
Positioning Yourself to Become an MSL in 2022

MSL role, clinical background, academic background, research background, industry, MSL Society, conference, scientific expert, therapeutic expertise, pharma companies

After attending the MSL Society’s 9th annual conference in Vegas Last week, I have taken some time to reflect on inquiries our team received about how to effectively step into the MSL role from a clinical, academic, or research background. Industry is a tough nut to crack, but it is absolutely…

Dec 21st • 10 mins read

Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility

clinical trials, industry, oncology, pediatric, sponsorship

The sponsorship mix of trials relevant to young people with cancer has not been well-documented, which may impact policies and regulations in pediatric cancer drug development. An analysis of interventional trials in the U.S. from 2007 to 2018 was conducted using the ClinicalTrials.gov registry, …

Apr 29th • 8 mins read

Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration
OVN Avatar Natansh D. Modi, BPharm; Ahmad Y. Abuhelwa, PhD; Ross A. McKinnon, PhD
Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration

IPD sharing, clinical trial transparency, FDA anticancer approvals, oncology trials, data accessibility, pharmaceutical industry

The study examines the eligibility for individual participant data (IPD) sharing from clinical trials that supported the FDA approval of anticancer medicines over the past 10 years. Of the 304 trials analyzed, 136 (45%) were eligible for IPD sharing, while 168 (55%) were not. IPD sharing rates v…

Jul 28th • 20 mins read

Patient involvement: A must-have in medicine development, but is it being overlooked in a cost-constrained environment?
Partner Avatar Envision Pharma Group
Patient involvement: A must-have in medicine development, but is it being overlooked in a cost-constrained environment?

patient engagement in pharma, patient-centric drug development, life sciences industry innovation, patient insights in medicine, regulatory compliance in patient engagement, patient involvement in clinical trials, benefits of patient advocacy, patient-cen

The life sciences industry is in a constant state of advancement, bringing more and more groundbreaking medicines, cutting-edge technologies, and innovative solutions to market. Amidst these rapid changes, patients remain at the heart of these scientific developments. In recent decades, the l…

May 9th • 5 mins read

The Value of Pharmaceutical Industry-Sponsored Patient Registries in Oncology Clinical Research
OVN Avatar E Dawn Flick, Howard R Terebelo, Susan Fish, Amani Kitali, Vrinda Mahajan, Melissa Nifenecker, Kristen Sullivan, Paul Thaler, Sarah Ussery, David L Grinblatt
The Value of Pharmaceutical Industry-Sponsored Patient Registries in Oncology Clinical Research

registry, oncology, observational study, prospective cohort study, real-world evidence

Oncology patient registries are valuable for generating Real-World Evidence (RWE) due to: Prospective, primary data collection Characterizing smaller patient populations not typically included in clinical trials Providing insights into the rapidly changing disease course Allowing for longitudi…

Jun 7th • 8 mins read

The Evidence REVEAL Study: Exploring the Use of Real-World Evidence and Complex Clinical Trial Design by the European Pharmaceutical Industry
OVN Avatar Peter Varnai, Anoushka Davé, Kristine Farla, Anke Nooijen, Liana Petrosova
The Evidence REVEAL Study: Exploring the Use of Real-World Evidence and Complex Clinical Trial Design by the European Pharmaceutical Industry

real world evidence, CCT, complex clinical trial

The European Medicines Agency (EMA) should develop an RWE framework for premarketing authorization in Europe. EMA and the European Medicines Regulatory Network (EMRN) could lead the development of RWE standards in the EU and beyond. Joint demonstration projects by the European Commission and ind…

Nov 20th • 10 mins read

Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled Analysis
OVN Avatar Alfredo Addeo, MD; Glen J. Weiss, MD, MBA; Bishal Gyawali, MD, PhD
Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled Analysis

pooled analysis, FDA, negative phase 3 trials, phase 3 trial, RCT, PRISMA, RCT's

In this study of trials published in 2016 through 2018, approximately 40% of negative phase 3 RCTs in oncology were conducted without supporting phase 2 trials, and such phase 3 trials were sponsored by both academia and industry. On the basis of our results, proactive steps from regulators and ethi…

May 10th • 8 mins read

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
OVN Avatar Jamie Riley
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

hiring, talent demand, job market

As pipelines advance and execution accelerates, pharma and biotech hiring may shift again in 2026, reshaping talent demand.

Feb 4th • 7 mins read

Large pharma companies reduced headcounts by more than 22K in 2025 as $300B patent cliff looms
OVN Avatar Angus Liu
Large pharma companies reduced headcounts by more than 22K in 2025 as $300B patent cliff looms

headcount, reduction, revenue per employee

Large pharmaceutical companies, each with at least $20 billion in 2025 revenue, collectively reduced their workforces by more than 22,000 employees last year.  Among the 17 largest pharma companies analyzed in a Fierce Pharma review of annual reports, only five logged a head count increase in 2025…

Mar 23rd • 10 mins read

Leadership Lab: 10 Ways Executives Can Stay Visible, Valuable Between Jobs
Partner Avatar Michael Pietrack
Leadership Lab: 10 Ways Executives Can Stay Visible, Valuable Between Jobs

careers

For biopharma executives who are between roles, navigating the transitionary time can be challenging. However, they can remain visible and valuable so they’re ready to seize their next big opportunity.

Oct 22nd • 5 mins read

Leadership Lab: Take a Cue From Athletes by Working With an Executive Coach
Partner Avatar Michael Pietrack
Leadership Lab: Take a Cue From Athletes by Working With an Executive Coach

careers

Executive coaches can help executives take their game to the next level in four key ways, from improving their self-awareness to reshaping their thinking.

Feb 19th • 6 mins read

Leadership Lab: 5 Ways Biopharma Execs Can Restore Trust, Retain Talent After Layoffs
Partner Avatar Michael Pietrack
Leadership Lab: 5 Ways Biopharma Execs Can Restore Trust, Retain Talent After Layoffs

careers

In the latest installment of his column, Kaye/Bassman’s Michael Pietrack shares five ways leaders can help their teams after a layoff, from acknowledging emotions to reestablishing culture.

Jun 25th • 4 mins read

Leadership Lab: 5 Steps for Building Your Personal Brand
Partner Avatar Michael Pietrack
Leadership Lab: 5 Steps for Building Your Personal Brand

careers

By building and nurturing a strong personal brand, you can benefit in multiple ways, including enhancing your credibility, attracting opportunities and inspiring investor confidence.

Aug 19th • 5 mins read

Leadership Lab: How To Spot When Employees Are About To Walk Away
Partner Avatar Michael Pietrack
Leadership Lab: How To Spot When Employees Are About To Walk Away

careers

Employees rarely leave companies for one reason alone. In this column, Kaye/Bassman’s Michael Pietrack shares a framework that helps leaders identify when their team members are thinking about heading for the exit—and how to address it.

Oct 22nd • 7 mins read

Managing Emotions After Being Downsized
Partner Avatar Michael Pietrack
Managing Emotions After Being Downsized

careers

The biggest challenge a person faces after being downsized is the wide range of emotions that follow. Over the past 15 years, I’ve observed many individuals deal with this unfortunate circumstance, and I wanted to share what I’ve seen others do to cope. I genuinely hope this helps you or someon…

Oct 21st • 5 mins read

Practical Advice for When You're Downsized. What Activities will Pay-off after a Lay-off?
Partner Avatar Michael Pietrack
Practical Advice for When You're Downsized. What Activities will Pay-off after a Lay-off?

careers

Have you or someone you know recently been downsized, laid off, or RIF’d? If so, you’re going to want to watch and share this video. When one is downsized, there is a range of emotions. Some feel betrayed and carry hurt feelings, while others fight with the fear of uncertainty and the reality…

Sep 15th • 5 mins read

Resume Advice: Tattoos and Breadcrumbs
Partner Avatar Michael Pietrack
Resume Advice: Tattoos and Breadcrumbs

careers

Okay, Pietrack has finally lost it! What do tattoos and breadcrumbs have to do with resume advice? If you did a web search seeking resume advice, you would get pages of information about resume construction to format to length. So much of how a resume should be constructed is subjective or based o…

Jul 14th • 5 mins read

How to Elevate Your Career: Go from Individual Contributor to People Leader
Partner Avatar Michael Pietrack
How to Elevate Your Career: Go from Individual Contributor to People Leader

careers

Have you ever wondered how to elevate from an individual contributor to a leadership position? Well, it's all about picking the right elevator. Imagine your current position as an elevator, and it has stopped at the seventh floor.  Despite pushing all the buttons, that elevator just will not go …

Jul 24th • 5 mins read

What Do Tennis and Job Interviewing Have in Common?
Partner Avatar Michael Pietrack
What Do Tennis and Job Interviewing Have in Common?

careers

What do tennis and Job interviewing have in common? In a game of tennis, one person sends the ball over the net and the other person, sends it back, right? Well, when it comes to job interviewing, correspondence with the hiring manager is a lot like tennis. How? When you send the ball over the ne…

Apr 14th • 5 mins read

Related Topics

Meet Our Innovation Partners

Loading partners...